Prostate Cancer - Results from #22220

Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence - Abstract October 30, 2013

Beyond abiraterone: New hormonal therapies for metastatic castration-resistant prostate cancer - Abstract October 30, 2013

New study in NEJM exposes overuse of radiation therapy services when urologists profit through self-referral October 30, 2013

Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: Decision curve analysis to evaluate predictive models - Abstract October 29, 2013

Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning - Abstract October 29, 2013

Spirituality in men with advanced prostate cancer: "It's a holistic thing . . . It's a package" - Abstract October 29, 2013

RTOG 0518: Randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients - Abstract October 29, 2013

Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer - Abstract October 29, 2013

Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: Long-term outcome of Chinese patients - Abstract October 29, 2013

Cigarette smoking and prostate cancer risk: Negative results of the Seoul Male Cancer Cohort Study - Abstract October 29, 2013

Controversies on individualized prostate cancer care: Gaps in current practice - Abstract October 29, 2013

Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy - Abstract October 29, 2013

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer - Abstract October 28, 2013

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported outcome results of a randomised phase 3 trial - Abstract October 28, 2013

Cancer-induced bone pain: Mechanisms and models - Abstract October 28, 2013

Learning curve in the application of a hydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer - Abstract October 28, 2013

Measuring and predicting prostate cancer related quality of life changes using the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) - Abstract October 28, 2013

Innovations in diagnostic imaging of localized prostate cancer - Abstract October 28, 2013

A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland - Abstract October 28, 2013

An evaluation of a community-academic-clinical partnership to reduce prostate cancer disparities in the South - Abstract October 28, 2013

Page 1112 of 1449